Skip to main content

Table 3 Comparison of probing pocket depths and probing attachment loss at baseline, 2 months and 3 months between NSPT and OHI group

From: Effect of nonsurgical periodontal therapy verses oral hygiene instructions on Type 2 diabetes subjects with chronic periodontitis: a randomised clinical trial

 

NSPT group (n = 15)

OHI group ( n = 17)

*p

†p

 

Sites with PPD < 4 mm (% ± SD)

Sites with PAL < 4 mm (% ± SD)

Sites with PPD < 4 mm (% ± SD)

Sites PAL < 4 mm (% ± SD)

  

Baseline

81.14 ± 13.38

63.45 ± 21.29

87.54 ± 15.00

75.98 ± 20.37

0.215

0.099

2 months

95.61 ± 3.50

71.60 ± 19.26

90.32 ± 15.29

78.99 ± 21.17

0.138

0.312

3 month

97.96 ± 1.75

74.93 ± 18.03

91.67 ± 14.86

80.10 ± 21.57

0.633

0.472

P1 value

<0.001*

<0.001*

0.001*

<0.001*

  

P2 value

<0.001*

<0.001*

<0.001*

<0.001*

  

P3 value

0.008*

0.002*

0.001*

0.005*

  

Effect Size1

1.205

0.822

0.991

0.792

  

Effect Size2

1.289

0.982

1.383

0.928

  

Effect size3

0.794

0.994

0.962

0.786

  
 

Sites with PPD

Sites with PAL

Sites with PPD

Sites with PAL

  
 

4-6 mm (% ± SD)

4-6 mm (% ± SD)

4-6 mm (% ± SD)

4-6 mm (% ± SD)

  

Baseline

16.51 ± 10.97

28.62 ± 16.19

11.00 ± 9.52

19.59 ± 12.06

0.201

0.082

2 months

4.28 ± 3.53

23.69 ± 16.84

8.54 ± 10.87

17.55 ± 13.72

0.158

0.264

3 month

2.04 ± 1.75

21.40 ± 16.06

7.31 ± 10.85

16.63 ± 14.44

0.381

0.384

P1 value

<0.001*

<0.001*

0.005*

<0.001*

  

P2 value

<0.001*

<0.001*

<0.001*

<0.001*

  

P3 value

0.012*

0.013*

0.002*

0.032*

  

Effect Size1

1.303

0.624

0.797

0.516

  

Effect Size2

1.371

0.769

1.127

0.619

  

Effect Size3

0.749

0.733

0.900

0.570

  
 

Sites with PPD

Sites with PAL

Sites with PPD

Sites with PAL

  
 

>6 mm (% ± SD)

>6 mm (% ± SD)

>6 mm (% ± SD)

>6 mm (% ± SD)

  

Baseline

2.36 ± 3.14

7.93 ± 7.87

1.54 ± 5.80

4.29 ± 9.77

0.115

0.260

2 months

0.06 ± 0.23

4.55 ± 4.64

1.14 ± 4.69

3.40 ± 8.91

0.074

0.656

3 month

0.00 ± 0.00

3.67 ± 4.06

1.02 ± 4.20

3.27 ± 8.40

0.356

0.869

P1 value

0.012*

0.001*

0.168

<0.001*

  

P2 value

0.012*

0.001*

0.203

<0.001*

  

P3 value

0.334

0.011*

0.332

0.407

  

Effect Size1

0.747

0.655

0.350

0.757

  

Effect Size2

0.749

0.803

0.322

0.612

  

Effect Size3

0.258

0.751

0.243

0.207

  
 

Mean PPD (mean ± SD)

Mean PAL (mean ± SD)

Mean PPD (mean ± SD)

Mean PAL (mean ± SD)

  

Baseline

2.56 ± 0.57

3.35 ± 0.83

2.29 ± 0.69

2.79 ± 0.96

0.535

0.089

2 months

1.94 ± 0.26

2.92 ± 0.72

2.09 ± 0.72

2.62 ± 0.97

0.459

0.329

3 months

1.76 ± 0.19

2.73 ± 0.70

2.02 ± 0.71

2.56 ± 0.97

0.179

0.560

P1 value

0.004*

<0.001*

<0.001*

<0.001*

  

P2 value

0.003*

<0.001*

<0.001*

<0.001*

  

P3 value

<0.001*

<0.001*

0.001*

0.002*

  

Effect Size1

0.873

1.893

1.090

1.396

  

Effect Size2

2.057

2.057

1.528

1.528

  

Effect Size3

1.506

1.697

0.967

1.282

  
  1. *p - intergroup p-value for PPD.
  2. †p - intergroup p-value for PAL.
  3. p1 - p-value of baseline compared to 2 months (*p < 0.05 - statistically significant).
  4. p2 - p-value of baseline compared to 3 months (*p < 0.05 - statistically significant).
  5. p3 – p-value of 2 months compared to 3 months (*p < 0.05 -statistically significant).
  6. Effect Size1 - effect size of baseline compared to 2 months.
  7. Effect Size2 – effect size of baseline compared to 3 months.
  8. Effect Size3 – effect size of 2 months compared to 3 months.
Back to article page

BMC Oral Health

ISSN: 1472-6831

Contact us